The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brunschwig, E. B.
Right arrow Articles by Tykocinski, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brunschwig, E. B.
Right arrow Articles by Tykocinski, M. L.

The Journal of Immunology, Vol 155, Issue 12 5498-5505, Copyright © 1995 by American Association of Immunologists

ARTICLES

Glycosylphosphatidylinositol-modified murine B7-1 and B7-2 retain costimulator function

EB Brunschwig, E Levine, U Trefzer and ML Tykocinski
Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.

Glycosylphosphatidylinositol (GPI)-modified variants of murine B7-1 and B7-2 cell surface costimulators were produced via chimerization with alternative GPI-modification signal sequences from decay-accelerating factor (DAF). GPI anchorage was verified by demonstrating phosphatidylinositol-specific phospholipase C (PI-PLC) sensitivity of the chimeric polypeptides in both immunofluorescence/flow-cytometric and immunoprecipitation analyses. The various GPI-modified chimeric B7- 1:DAF and B7-2:DAF polypeptides were shown to retain costimulator function, in both an in vitro proliferation assay and an in vivo triggering of cytotoxicity assay. The findings indicate that costimulator function for both B7-1 and B7-2 is not dependent upon native hydrophobic transmembrane anchorage. Moreover, the functionality of the GPI-modified variants in enhancing the immunogenicity of the murine T lymphoma line EL-4 suggests a novel route for generating APC- centered immunotherapeutics, including cellular cancer vaccines, that is based upon protein transfer of GPI-modified costimulators.


This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Paust, L. Lu, N. McCarty, and H. Cantor
Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease
PNAS, July 13, 2004; 101(28): 10398 - 10403.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Rachmilewitz, Z. Borovsky, G. J. Riely, R. Miller, and M. L. Tykocinski
Negative Regulation of T Cell Activation by Placental Protein 14 Is Mediated by the Tyrosine Phosphatase Receptor CD45
J. Biol. Chem., April 11, 2003; 278(16): 14059 - 14065.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Rachmilewitz, Z. Borovsky, G. Mishan-Eisenberg, E. Yaniv, G. J. Riely, and M. L. Tykocinski
Focal Localization of Placental Protein 14 Toward Sites of TCR Engagement
J. Immunol., March 15, 2002; 168(6): 2745 - 2750.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
J. Rachmilewitz, G. J. Riely, J.-H. Huang, A. Chen, and M. L. Tykocinski
A rheostatic mechanism for T-cell inhibition based on elevation of activation thresholds
Blood, December 15, 2001; 98(13): 3727 - 3732.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. Zheng, A. Chen, R. E. Sterner, P. J. Zhang, T. Pan, N. Kiyatkin, and M. L. Tykocinski
Induction of Antitumor Immunity via Intratumoral Tetra-Costimulator Protein Transfer
Cancer Res., November 1, 2001; 61(22): 8127 - 8134.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
J.-H. Huang and M. L. Tykocinski
CTLA-4-Fas ligand functions as a trans signal converter protein in bridging antigen-presenting cells and T cells
Int. Immunol., April 1, 2001; 13(4): 529 - 539.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. L. van Broekhoven, C. R. Parish, G. Vassiliou, and J. G. Altin
Engrafting Costimulator Molecules onto Tumor Cell Surfaces with Chelator Lipids: A Potentially Convenient Approach in Cancer Vaccine Development
J. Immunol., March 1, 2000; 164(5): 2433 - 2443.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Chen, G. Zheng, and M. L. Tykocinski
Hierarchical Costimulator Thresholds for Distinct Immune Responses: Application of a Novel Two-Step Fc Fusion Protein Transfer Method
J. Immunol., January 15, 2000; 164(2): 705 - 711.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
R. S. McHugh, S. Nagarajan, Y.-C. Wang, K. W. Sell, and P. Selvaraj
Protein Transfer of Glycosyl-phosphatidylinositol-B7-1 into Tumor Cell Membranes: A Novel Approach to Tumor Immunotherapy
Cancer Res., May 1, 1999; 59(10): 2433 - 2437.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
M. Ferguson
The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research
J. Cell Sci., January 9, 1999; 112(17): 2799 - 2809.
[Abstract] [PDF]

Home page
 J. Immunol.Home page
R. T. Doty and E. A. Clark
Two Regions in the CD80 Cytoplasmic Tail Regulate CD80 Redistribution and T Cell Costimulation
J. Immunol., September 15, 1998; 161(6): 2700 - 2707.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.